BIONET Past Earnings Performance
Past criteria checks 2/6
BIONET has been growing earnings at an average annual rate of 44.6%, while the Healthcare industry saw earnings growing at 6.8% annually. Revenues have been growing at an average rate of 9% per year. BIONET's return on equity is 3.2%, and it has net margins of 5.4%.
Key information
44.6%
Earnings growth rate
44.9%
EPS growth rate
| Healthcare Industry Growth | 9.1% |
| Revenue growth rate | 9.0% |
| Return on equity | 3.2% |
| Net Margin | 5.4% |
| Last Earnings Update | 30 Jun 2024 |
Recent past performance updates
Revenue & Expenses Breakdown
How BIONET makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 30 Jun 24 | 1,163 | 63 | 451 | 132 |
| 31 Mar 24 | 1,166 | 77 | 446 | 127 |
| 31 Dec 23 | 1,127 | 78 | 435 | 119 |
| 30 Sep 23 | 1,105 | 84 | 426 | 111 |
| 30 Jun 23 | 1,062 | 81 | 413 | 96 |
| 31 Mar 23 | 1,008 | 57 | 398 | 93 |
| 31 Dec 22 | 980 | 38 | 395 | 90 |
| 30 Sep 22 | 937 | 25 | 390 | 91 |
| 30 Jun 22 | 918 | 15 | 380 | 94 |
| 31 Mar 22 | 921 | 19 | 384 | 92 |
| 31 Dec 21 | 921 | 27 | 386 | 86 |
| 30 Sep 21 | 921 | 35 | 386 | 72 |
| 30 Jun 21 | 904 | 31 | 388 | 61 |
| 31 Mar 21 | 842 | 19 | 376 | 55 |
| 31 Dec 20 | 807 | 13 | 363 | 52 |
| 30 Sep 20 | 786 | 6 | 357 | 55 |
| 30 Jun 20 | 763 | 4 | 352 | 54 |
| 31 Mar 20 | 784 | 3 | 363 | 50 |
| 31 Dec 19 | 776 | 7 | 367 | 47 |
| 30 Sep 19 | 791 | 14 | 375 | 43 |
| 30 Jun 19 | 785 | 18 | 377 | 42 |
| 31 Mar 19 | 770 | 23 | 374 | 42 |
| 31 Dec 18 | 771 | 24 | 366 | 43 |
| 30 Sep 18 | 748 | 18 | 356 | 44 |
| 30 Jun 18 | 741 | 12 | 352 | 43 |
| 31 Mar 18 | 716 | 5 | 336 | 40 |
| 31 Dec 17 | 697 | -6 | 330 | 39 |
| 30 Sep 17 | 673 | -11 | 320 | 37 |
| 30 Jun 17 | 689 | -11 | 313 | 36 |
| 31 Mar 17 | 689 | -13 | 318 | 37 |
| 31 Dec 16 | 679 | -9 | 322 | 38 |
| 30 Sep 16 | 672 | -2 | 317 | 39 |
| 30 Jun 16 | 639 | 5 | 321 | 42 |
| 31 Mar 16 | 643 | 16 | 306 | 45 |
| 31 Dec 15 | 622 | 23 | 299 | 50 |
| 30 Sep 15 | 618 | 19 | 314 | 52 |
| 30 Jun 15 | 614 | 24 | 311 | 54 |
| 31 Mar 15 | 618 | 31 | 317 | 54 |
| 31 Dec 14 | 624 | 44 | 312 | 51 |
| 30 Sep 14 | 636 | 41 | 310 | 49 |
| 30 Jun 14 | 662 | 53 | 307 | 49 |
| 31 Mar 14 | 667 | 44 | 329 | 46 |
| 31 Dec 13 | 694 | 52 | 339 | 45 |
Quality Earnings: 1784 has high quality earnings.
Growing Profit Margin: 1784's current net profit margins (5.4%) are lower than last year (7.6%).
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: 1784's earnings have grown significantly by 44.6% per year over the past 5 years.
Accelerating Growth: 1784's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.
Earnings vs Industry: 1784 had negative earnings growth (-22.4%) over the past year, making it difficult to compare to the Healthcare industry average (3.6%).
Return on Equity
High ROE: 1784's Return on Equity (3.2%) is considered low.